Glassware combines safety and performance

Published: 17-Aug-2011
Manufacturing Analysis

KIMAX GL 45 storage/media bottles are made with Type 1 Class A borosilicate glass

Kimble Chase, a US manufacturer of laboratory glassware products, has introduced KIMAX GL 45 storage/media bottles in sizes from 100ml to 10,000ml. They are manufactured with Type 1 Class A borosilicate glass for durable performance and resistance to thermal stress.

The bottles are available with linerless, autoclavable (up to 140°C) polypropylene GL 45 caps with an internal seal. For easy identification, they can be specified with blue, white or orange caps.

Other caps available include a red PBT (polybutyleneterephthalate) cap with PTFE/silicone liner (up to 180°C) offering resistance to solvents and acids.

A blue vented cap (up to 140°C) is also available for equalising pressure during autoclaving. An extra wide neck opening facilitates access, and replaceable polypropylene pour rings minimise drips while pouring.

KIMAX storage/media bottles feature permanent, white enamel graduations and marking spots. For enhanced safety, the bottles may be treated with KimCote, an ultra-clear coating that is applied to the exterior of laboratory glassware to resist breakage and contain leaking.

For light-sensitive compounds, Kimble Chase offers RAY-SORB treated glassware.

Kimble Chase Life Science and Research Products, based in Vineland, New Jersey, was formed in July 2007 through a joint venture between specific operations of Thermo Fisher Scientific and Gerresheimer Glass. The company designs and manufactures reusable, disposable and specialist glassware for laboratories across a range of industries, including pharmaceuticals and life sciences.

See more

You may also like

Analysis

Laboratory glassware care partnership announced

Read more
Miele and DWK Life Sciences have announced a partnership to provide training initiatives for glassware care

Trending Articles

  1. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  2. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  3. Abzena and Mabqi announce strategic partnership to offer integrated discovery through development solution This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution
  4. Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Executive with over 20 years of management experience to lead pharmaceutical packaging and delivery systems company
  5. Efficient extraction of proteins from bacterial cells SoluLyse from Amsbio is a bacterial protein extraction reagent that provides a highly efficient yet gentle method for extracting soluble proteins from bacterial cells

You may also like

Analysis

Laboratory glassware care partnership announced

Miele and DWK Life Sciences have announced a partnership to provide training initiatives for glassware care
Analysis

Wheaton presents MicroLiter certified clean vials to the European market

MicroLiter, a Wheaton brand, offers proven autosampler vials and consumables for the chromatographer
Manufacturing

Coated glassware protects scientists

Kimble Chase introduces a proprietary glassware coating to provide an added measure of safety for scientists working with harmful substances
Manufacturing

Pioneering Peptide-Builder debuts at UEA

Vapourtec kept it local with the first ever installation of their pioneering production Peptide-Builder system taking place at the University of East Anglia (UEA) in Norwich
Manufacturing

Moderna invests $140m to onshore drug product manufacturing and complete US end-to-end mRNA network

Moderna is expanding its Norwood, Massachusetts site to bring drug product manufacturing in-house, creating hundreds of biomanufacturing jobs and establishing full domestic, end-to-end production for its mRNA vaccines and therapeutics by 2027
Sustainability

Free online course introduces fundamentals of SFC

Learn how SFC can improve efficiency and reduce environmental impact
Manufacturing

GEA to showcase Rockwell Automation-Compatible GEA kytero 2000 Single-Use Separator at Automation Fair 2025

As a gold-level OEM member of the Rockwell PartnerNetwork™, GEA is strengthening its collaboration with Rockwell by offering full compatibility between the kytero® 2000 and Rockwell’s latest hardware and software suite
Subscribe now